Alteration of tear mucin 5AC in office workers using visual display terminals: The Osaka study

Uchino Y., Uchino M., Yokoi N., Dogru M., Kawashima M., Okada N., Inaba T., Tamaki S., Komuro A., Sonomura Y., Kato H., Argüeso P., Kinoshita S., Tsubota K.

2014
JAMA Ophthalmology

View publication

Therapeutic Area

Front of the eye (FOTE)
Categories

Clinical development

Affiliations

Department of Ophthalmology, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan; Ryogoku Eye Clinic, Tokyo, Japan; Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan; Santen Pharmaceutical Co, Ltd, Osaka, Japan; Schepens Eye Research Institute and Massachusetts Eye and Ear, Department of Ophthalmology, Harvard Medical School, Boston, MA, United States

Related Publications

Efficacy and Tolerance of Nova22007 Versus Vehicle in Patients With Vernal Keratoconjunctivitis (NOVATIVE): A Phase II/III, Multicenter, Double-masked, Randomized Study of 0.05% Cyclosporine A and 0.1% Ophthalmic Cationic Emulsion Versus Vehicle in Patients With Vernal Keratoconjunctivitis

Leonardi A, Pisella PJ, Benítez-Del-Castillo JM, Amrane M, Ismail D, Doan S, Bremond-Gignac D.

Correlation between gene expression and clinical scores in vernal keratoconjunctivitis

Leonardi A, Cavarzeran F, Rosani U, Righetti G, Garrigue JS, Brun P.

Topical cyclosporine A cationic ophthalmic emulsion in paediatric vernal keratoconjunctivitis: pooled analysis of randomised NOVATIVE and VEKTIS trials

Leonardi A, Doan S, Aragona P, Amrane M, Ismail D, Montero J, Németh J, Bremond-Gignac D

View all Front of the eye (FOTE) publications